IntelGenx Technologies (IGXT) News Today $0.17 0.00 (0.00%) (As of 11/19/2024 ET) Add Compare Share Share Headlines Stock AnalysisChartEarningsFinancialsHeadlinesSEC FilingsShort Interest All Sources Trusted Sources MarketBeat.com Benzinga Bloomberg GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha The Street TipRanks The Wall Street Journal Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 August 2022 July 2022 June 2022 May 2022 April 2022 March 2022 February 2022 January 2022 December 2021 Time Period Intelgenx Technologies (OTC:IGXT) Stock Quotes, Forecast and News SummaryAugust 18, 2024 | benzinga.comIntelGenx Technologies Corp.: IntelGenx Provides Update on Previously Announced Sale and Investment Solicitation ProcessJuly 20, 2024 | finanznachrichten.deIntelGenx Provides Update on Previously Announced Sale and Investment Solicitation ProcessJuly 19, 2024 | globenewswire.comIntelGenx Obtains Preliminary Efficacy Results for the ‘BUENA' Montelukast VersaFilm® Phase 2a Clinical Trial in Patients with Mild to Moderate Alzheimer's DiseaseJuly 3, 2024 | globenewswire.comIntelGenx Announces Initiation of the Sale and Investment Solicitation ProcessJune 11, 2024 | globenewswire.comIntelGenx Obtains Court-Approval of a Sale and Investment Solicitation ProcessMay 28, 2024 | globenewswire.comIntelGenx Initiates Restructuring Proceedings Under the CCAA to Implement a Review of its Strategic AlternativesMay 17, 2024 | globenewswire.comIntelGenx Initiates Restructuring Proceedings Under the CCAA to Implement a Review of its Strategic AlternativesMay 17, 2024 | globenewswire.comIntelGenx Announces Voting Results on Election of DirectorsMay 8, 2024 | globenewswire.comIntelGenx Announces First Parkinson’s Disease Patients Dosed with Montelukast VersaFilm® in Phase 2 ‘MONTPARK’ Clinical TrialApril 8, 2024 | finance.yahoo.comIntelGenx Announces First Parkinson's Disease Patients Dosed with Montelukast VersaFilm® in Phase 2 ‘MONTPARK' Clinical TrialApril 8, 2024 | globenewswire.comIntelGenx Updates Status of Buprenorphine Buccal Film ANDAApril 5, 2024 | globenewswire.comIntelGenx Technologies Corp. (IGXT) Q4 2023 Earnings Call TranscriptMarch 23, 2024 | seekingalpha.comIntelGenx Technologies Corp. (PNK:IGXT) Q4 2023 Earnings Call TranscriptMarch 22, 2024 | insidermonkey.comIGXT Stock Earnings: Intelgenx Technologies Reported Results for Q4 2023March 21, 2024 | investorplace.comIntelGenx Reports Fourth Quarter and Full-Year 2023 Financial ResultsMarch 21, 2024 | globenewswire.comIGXT IntelGenx Technologies Corp.March 16, 2024 | seekingalpha.comIntelGenx to Report Fourth Quarter and Full Year 2023 Financial Results on March 21, 2024 – Conference Call to FollowMarch 14, 2024 | globenewswire.comIntelGenx Enters Into a Third Amended and Restated Loan Agreement With atai Life SciencesMarch 11, 2024 | globenewswire.comUPDATE -- IntelGenx Launches Preferred Share Regulation A OfferingFebruary 20, 2024 | finance.yahoo.comUPDATE -- IntelGenx Launches Preferred Share Regulation A OfferingFebruary 20, 2024 | globenewswire.comIntelGenx Launches Preferred Share Regulation A OfferingFebruary 20, 2024 | globenewswire.comIntelGenx Technologies Corp. (IGXT)February 19, 2024 | finance.yahoo.comStudies Validate Advantages of Administering Drugs to Pets via IntelGenx’s VetaFilm® PlatformFebruary 5, 2024 | finance.yahoo.comIntelgenx Technologies Corp IGXTDecember 7, 2023 | morningstar.comIntelGenx Receives Approval to Conduct ’MONTPARK’ Montelukast VersaFilm® Phase 2 Clinical Trial in Patients with Parkinson's DiseaseNovember 14, 2023 | finance.yahoo.comIntelGenx Reminds Shareholders to Vote at Upcoming Special MeetingNovember 13, 2023 | finance.yahoo.comIntelGenx Technologies Corp. (PNK:IGXT) Q3 2023 Earnings Call TranscriptNovember 10, 2023 | insidermonkey.comIntelGenx Reports Third Quarter 2023 Financial ResultsNovember 9, 2023 | finance.yahoo.comIntelGenx Announces Co-development and Commercialization of Cannabinoid-Infused VersaFilm® Products with TilrayNovember 6, 2023 | finance.yahoo.comIntelGenx Provides RIZAFILM® U.S. Commercialization UpdateSeptember 21, 2023 | finance.yahoo.comIntelGenx Announces Closing of First Tranche of Non-Brokered Private Placement From Strategic Partner for Approximate Aggregate Gross Proceeds of US$3 Million (Including US$750,000 to be Received by the Company Once Shareholder Approvals Have Been Obtained)August 31, 2023 | finance.yahoo.comIntelGenx Technologies Corp.: IntelGenx Reports Second Quarter 2023 Financial ResultsAugust 16, 2023 | finanznachrichten.deIntelGenx Technologies Corp. (PNK:IGXT) Q2 2023 Earnings Call TranscriptAugust 15, 2023 | finance.yahoo.comIntelGenx Technologies Corp. (IGXT) Q2 2023 Earnings Call TranscriptAugust 15, 2023 | finance.yahoo.comIntelGenx Reports Second Quarter 2023 Financial ResultsAugust 14, 2023 | finance.yahoo.comIntelGenx Announces First Agreement for CDMO Packaging ServicesAugust 10, 2023 | finance.yahoo.comIntelGenx to Report Second Quarter 2023 Financial Results on August 14, 2023 – Conference Call to FollowAugust 8, 2023 | finance.yahoo.comIntelGenx Completes Enrollment for ‘BUENA’ Montelukast VersaFilm® Phase 2a Clinical Trial in Patients with Mild to Moderate Alzheimer’s DiseaseAugust 1, 2023 | finance.yahoo.comIntelGenx Announces a Change to its Board of DirectorsJuly 21, 2023 | finance.yahoo.comIntelGenx Announces Voting Results on Election of DirectorsJuly 6, 2023 | finance.yahoo.comIGXT - IntelGenx Technologies Corp.June 16, 2023 | uk.finance.yahoo.comIntelGenx Receives Amended DEL License to Conduct Third-Party TestingMay 17, 2023 | finance.yahoo.comFDA Gives Nod To IntelGenx's Migraine Solution As Revenues Plunge 32%; Q1 Results ReportMay 11, 2023 | msn.comIntelGenx Reports First Quarter 2023 Financial ResultsMay 11, 2023 | finance.yahoo.comIntelGenx to Report First Quarter 2023 Financial Results on May 11, 2023 – Conference Call to FollowMay 4, 2023 | finance.yahoo.comClosing Bell: Intelgenx Technologies Corp down on Friday (IGX)April 22, 2023 | theglobeandmail.comClosing Bell: Intelgenx Technologies Corp down on Tuesday (IGX)April 19, 2023 | theglobeandmail.comIntelGenx Technologies Corp.: IntelGenx Announces FDA Approval of RIZAFILM for the Treatment of Acute MigraineApril 17, 2023 | finanznachrichten.deIntelGenx Announces FDA Approval of RIZAFILM® for the Treatment of Acute MigraineApril 17, 2023 | finance.yahoo.com Get IntelGenx Technologies News Delivered to You Automatically Sign up to receive the latest news and ratings for IGXT and its competitors with MarketBeat's FREE daily newsletter. Email Address [625,000% Gain] – Are You Ready for the Next Altcoin Boom? (Ad)All of our key indicators are flashing the same signal: an altcoin season is fast approaching. And if you know anything about crypto, you know that altcoin seasons are where some of the biggest gains happen. Register for the FREE Workshop Now & get $10 in Bitcoin IGXT Media Mentions By Week IGXT Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. IGXT News Sentiment▼0.000.46▲Average Medical News Sentiment IGXT News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. IGXT Articles This Week▼00▲IGXT Articles Average Week Get IntelGenx Technologies News Delivered to You Automatically Sign up to receive the latest news and ratings for IGXT and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies Alto Neuroscience News Today Avalo Therapeutics News Today InflaRx News Today Journey Medical News Today Cidara Therapeutics News Today Vaxart News Today Rani Therapeutics News Today Cellectis News Today Century Therapeutics News Today Adlai Nortye News Today Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (OTCMKTS:IGXT) was last updated on 11/21/2024 by MarketBeat.com Staff From Our PartnersThe Crypto That’s Making Wall Street SweatThe Crypto Wall Street Is Desperate to Hide It's happening now, right under everyone's radar. Big tech gian...Crypto 101 Media | SponsoredMissed Nvidia? Watch this ASAPThis little-known project that Bill Gates has been quietly working on that’s about to unleash an AI breakthrou...Brownstone Research | SponsoredMusk’s new company could top a trillion?The investment legend who predicted the rise of Bitcoin, Facebook and streaming services like Netflix… Just...Paradigm Press | Sponsored24/7 Automated Profits in CryptoWhat if you could make consistent daily profits in crypto with minimal effort? Beyond trading lies a vast w...Crypto Swap Profits | SponsoredCrypto’s next big bull run?Juan Villaverde may be America’s top crypto expert. And he says something big is coming for crypto – on Nov...Weiss Ratings | Sponsored“This Changes Everything” - Trump Hands Millions Massive IRS GiftNow it's your time to return the favor by taking advantage of this tax "revenge loophole." Because even as ...Colonial Metals | SponsoredTim Sykes’ Urgent Trade Alert: “Make this move now”WARNING: 80 Wall Street banks are gearing up for MASSIVE D.C. shock This $2 trillion D.C. shock is NOT abou...Timothy Sykes | SponsoredUnveiled: NVIDIA’s "Secret Royalty" ProgramDid you know that there's an investment that will give you the opportunity to collect "royalties" every time N...Behind the Markets | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding IntelGenx Technologies Corp. Please log in to your account or sign up in order to add this asset to your watchlist. Share IntelGenx Technologies With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
